[Federal Register Volume 78, Number 126 (Monday, July 1, 2013)]
[Notices]
[Page 39338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-15588]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Catalent CTS., Inc.

    By Notice dated April 10, 2013, and published in the Federal 
Register on April 19, 2013, 78 FR 23594, Catalent CTS., Inc., 10245 
Hickman Mills Drive, Kansas City, Missouri 64137, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import a finished pharmaceutical product 
containing cannabis extracts in dosage form, to package for a clinical 
trial study. In addition, the company also plans to import an ointment 
for the treatment of wounds, which contains trace amounts of the 
controlled substance normally found in poppy straw concentrate for 
packaging and labeling for clinical trials.
    Comments and requests for any hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417(2007).
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Catalent CTS., Inc., to import the basic classes of 
controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971.
    DEA has investigated Catalent CTS., Inc., to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic classes of controlled 
substances listed.

     Dated: June 18, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-15588 Filed 6-28-13; 8:45 am]
BILLING CODE 4410-09-P